NM_001943.5(DSG2):c.1374_1388del (p.Arg458_Gly463delinsSer) AND Arrhythmogenic right ventricular cardiomyopathy, type 10

Clinical significance:Uncertain significance (Last evaluated: Sep 11, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_001943.5(DSG2):c.1374_1388del (p.Arg458_Gly463delinsSer)]

NM_001943.5(DSG2):c.1374_1388del (p.Arg458_Gly463delinsSer)

DSG2:desmoglein 2 [Gene - OMIM - HGNC]
Variant type:
Cytogenetic location:
Genomic location:
Preferred name:
NM_001943.5(DSG2):c.1374_1388del (p.Arg458_Gly463delinsSer)
  • NC_000018.10:g.31535363_31535377del
  • NG_007072.3:g.42122_42136del
  • NM_001943.5:c.1374_1388delMANE SELECT
  • NP_001934.2:p.Arg458_Gly463delinsSer
  • LRG_397:g.42122_42136del
  • NC_000018.9:g.29115325_29115339del
  • NC_000018.9:g.29115326_29115340del
Molecular consequence:
  • NM_001943.5:c.1374_1388del - inframe_indel - [Sequence Ontology: SO:0001820]


Arrhythmogenic right ventricular cardiomyopathy, type 10 (ARVD10)
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; Arrhythmogenic right ventricular dysplasia type 10; Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy10
MONDO: MONDO:0012434; MedGen: C1857777; OMIM: 610193

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001511584Invitaecriteria provided, single submitter
Uncertain significance
(Sep 11, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

Details of each submission

From Invitae, SCV001511584.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)


This variant, c.1374_1388del, results in the deletion of 6 and insertion of 1 amino acid(s) in the DSG2 protein (p.Arg458_Gly463delinsSer), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with DSG2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 17, 2021

Support Center